Anti-Phosphatidylserine Monoclonal Antibody: Structural Template for Studying Lipid-Protein Interactions and for Identificationo of Phosphatidylserine Binding Proteins

  • Masato Umeda
  • Koji Igarashi
  • Shigeru Tokita
  • Farooq Reza
  • Keizo Inoue
Conference paper
Part of the Nato ASI Series book series (NATO ASI, volume 70)

Abstract

Although phosphatidylserine (PS) is an essential component for the formation of membrane bilayers, it has been shown to contribute to many regulatory processes in biological responses (Kaibuchi et al., 1981, Zwaal et al., 1986, Madsen et al., 1989, Inoue et al., 1989). Pharmacological effects of PS have also been reported (Bruni et al., 1976, 1989). Some PS may exhibit biological activity through interacting with specific binding proteins. Some of the proteins were shown to interact with PS in a highly specific manner and precise configurations of PS molecule are required for the interaction. The typical examples are the receptor for lyso-PS on rat mast cells (Horigome et al., 1986, Chang et al., 1988), aminophospholipid translocase (Morrot et al., 1989) and protein kinase C (Lee and Bell, 1989). The PS-binding proteins so far reported are listed in Table 1. Although much effort has been focused on understanding the molecular mechanism involved in the interactions between PS and PS-binding proteins, the difficulties of handling these proteins because of their limited aqueous solubility and scarcity in the biological systems have hampered progress in this area.

Keywords

Heparin Serine Choline Dextran Phosphatidylcholine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen TM, Willianson P, Schlegel RA (1988) Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc.Natl.Acad.Sci.USA 85:8067–8071PubMedCrossRefGoogle Scholar
  2. Alving C., (1986) Antibodies to liposomes, phospholipids and phosphate esters. Chem.Phys.Lipids 40:303–314PubMedCrossRefGoogle Scholar
  3. Arai M, Scandella D, Hoyer LW (1989) Molecular basis of factor VIII inhibition by human antibodies. J.Clin.Invest. 83:1978–1984PubMedCrossRefGoogle Scholar
  4. Benfenati F, Greengard P, Burunner J, Bahler M (1989) Electrostatic and hydrophobic interaction of synapsin I and synapsin I fragments with phospholipid bilayers. J.Cell Biol. 108:1851–1862PubMedCrossRefGoogle Scholar
  5. Bloom JW (1987) The interaction of rDNA factor VIII des-797–1562 and factor VIII des-797–1562-derived peptides with phospholipid. Thromb.Res. 48:439–448PubMedCrossRefGoogle Scholar
  6. Bruni A, Toffano G, Leon A, Boarato E. (1976) Pharmacological effects of phosphatidylserine liposome. Nature (London) 260:331–333CrossRefGoogle Scholar
  7. Bruni A, Mietto L, Bellini F, Boarato E, Toffano G. (1989) Pharmacological and autopharmacological action of phosphatidylserine. Phospholipids in the Nervous System: Bazan NG, Horrocks LA, Toffano G (eds) Fidia Research Series. Vol 17:217–224Google Scholar
  8. Burgener R, Wolf M, Ganz T, Gaggiolini M (1990) Purification and characterization of major phosphatidylserine-binding phosphoprotein from human platelets. Biochem.J. 269:729–734PubMedGoogle Scholar
  9. Chang HW, Inoue K, Bruni A, Boarato E, Toffano G (1988) Stereoselective effects of lysophosphatidylserine in rodents. Br.J.Pharmacol. 93:647–653PubMedCrossRefGoogle Scholar
  10. Chothia C., Lesk AM, Levitt M, Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ (1986) The predicted structure of immunoglobulin D 1.3 and its comparison with the crystal structure. Science 233:755–758PubMedCrossRefGoogle Scholar
  11. Chothia C., Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ (1989) Comformations of immunoglobulin hypervariable regions. Nature 342:877–883PubMedCrossRefGoogle Scholar
  12. Gaulton GN, Greene MI (1986) Idiotypic mimicry of biological receptors. Annu.Rev.Immunol. 4:253–280PubMedCrossRefGoogle Scholar
  13. Ghoson S, Campbell AM (1986) Multispecific monoclonal antibodies. Immonol.Today 7:217–222CrossRefGoogle Scholar
  14. Harris EN, Asherson RA, Hughes GRV (1988) Antiphospholipid antibodies-autoantibodies with a difference. Annu.Rev.Med. 39:261–271PubMedCrossRefGoogle Scholar
  15. Higashi S, Kobayashi T, Kudo I, Inoue K (1988) Purification and characterization of lysophospholipase released from rat platelets. J.Biochem. 103:442–447PubMedGoogle Scholar
  16. Horigome H, Tamori-Natori Y, Inoue K, Nojima S (1986) Effect of serine phospholipid structure on the enhancement of concanavalin A-induced degranulation in rat mast cells. J.Biochem. 100:571–579PubMedGoogle Scholar
  17. Horigome K, Hayakawa M, Inoue K, Nojima S (1987) Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J.Biochem. 101:53–61PubMedCrossRefGoogle Scholar
  18. Igarashi K, Umeda M, Tokita S, Nam KS, Inoue K (1991) Effective induction of antiphospholipid and anticoagulant antibodies in normal mouse. Thromb.Res. 61:135–148PubMedCrossRefGoogle Scholar
  19. Inoue K, Kobayashi T, Kudo I (1989) Function and metabolism of lysophosphatidylserine in rat mast cell activation. Phospholipids in the Nervous System: Bazan NO, Horrocks LA, Toffano G (eds) Fidia Research Series. Vol 17:225–231Google Scholar
  20. Ito E, Miyazawa A, Takagi H, Yoshioka T, Horikoshi T, Yanagisawa K, Nakamura T, Kudo Y, Umeda M, Inoue K, Mikoshiba K (1991) Developmental assembly of calcium-mobilizing systems for excitatory amino acids in rat cerebellum. Neurosci. Res. 11:179–188.PubMedCrossRefGoogle Scholar
  21. Janoff A, Rauch J (1986) The structural specificity of antiphospholipid antobodies in autoimmune disease. Chem.Phys.Lipids 40:315–332PubMedCrossRefGoogle Scholar
  22. Kaetzel MA, Hazarika P, Dedman JR (1989) Differential tissue exprossion of three 35-KDa annexin calcium-dependent phospholipid-binding proteins. J.Biol.Chem. 264:14463–14470PubMedGoogle Scholar
  23. Kaibuchi K, Takai Y, Nishizuka Y (1981) Cooperative roles of various membrane phospholipids in the activation of calcium-activated, phospholipid-dependent protein kinase. J.Biol.Chem. 256:7146–7149PubMedGoogle Scholar
  24. Kimura H, Cook R, Meek K, Umeda M, Ball E, Capra JD, Marcus DM. (1988) Sequences of the Vh and VI regions of murine monoclonal antibodies against 3-fucosyllactosamine. J.Immunol. 140:1212–1217PubMedGoogle Scholar
  25. Kimura H, Buescher ES, Ball ED, Marcus DM (1989) Restricted usage of Vh and Vk genes by murine monoclonal antibodies against 3-fucosyllactosamine. Eur. J.Immunol. 19:1741–1746PubMedCrossRefGoogle Scholar
  26. Lajmanovich A, Clergeon GH, Freyssinet JM, Marguerie G (1981) Human factor VIII procoagulant activity and phospholipid interaction. Biochim.Biophys.Acta, 678:132–136PubMedCrossRefGoogle Scholar
  27. Lee MH, Bell RM (1989) Phospholipid functional groups involved in protein kinase C activation, phorbol ester binding, and binding to mixed micelles. J.Biol.Chem. 264:14797–14805PubMedGoogle Scholar
  28. Madsen J, Connor J, Schroit AAJ (1989) Recognition of phosphatidylserine by the reticuloendothelial system. Phospholipids in the Nervous System: Bazan NG, Horrocks LA, Toffano G (eds) Fidia Research Series. Vol 17:3–10Google Scholar
  29. Mann KG, Jenny RJ, Krishnaswamy S (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Ann.Rev.Biochem. 57:915–956PubMedCrossRefGoogle Scholar
  30. Martin OC, and Pagano RE (1987) Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. J.Biol.Chem. 262:5890–5898PubMedGoogle Scholar
  31. Miyazawa A, Umeda M, Horikoshi T, Yanagisawa K, Yoshioka T, Inoue K. (1988) Production and characterization of monoclonal antibodies that bind to phosphatidylinositol 4,5-bisphosphate. Molecular Immunol. 25:1025–1031CrossRefGoogle Scholar
  32. Morrot G, Herve P, Zachowski A, Fellmann P, Devaux PF, (1989) Aminophospholipid translocase of human erythrocytes: phospholipid substrate specificity and effect of cholesterol. Biochemistry 28:3456–3462PubMedCrossRefGoogle Scholar
  33. Murakami M, Kudo I, Umeda M, Komada M, Fujimori Y, Takahashi K, Inoue K (1991) Cultured mast cells express three distinct phospholipase A2. submitted.Google Scholar
  34. Nam KS, Igarashi K, Umeda M, Inoue K (1990a) Production and characterization of monoclonal antibodies that specifically bind to phosphatidylcholine. Biochim.Biophys. Acta 1046:89–96PubMedCrossRefGoogle Scholar
  35. Nam KS, Umeda M, Igarashi K, Inoue K (1990b) Anti-idiotypic antibody identifies the structural similarity between the phosphatidylcholine-specific monoclonal antibody and phosphatidylcholine-specific transfer protein. FEBS Lett. 269:394–397PubMedCrossRefGoogle Scholar
  36. Nishikawa K, Arai H, Inoue K (1990) Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J.Biol.Chem. 265:5226–5231PubMedGoogle Scholar
  37. Novotny J, Bruccoleri R, Newell J, Murphy D, Haber E, Karplus M (1983) Molecular anatomy of the antibody binding site. J.Biol.Chem. 258:14433–14437PubMedGoogle Scholar
  38. Padlan EA, Kabat EA (1988) Model-building study of the combining sites of two antibodies to α(1→6)dextran. Pro.Nat.Acad.Sci.USA 85:6885–6889CrossRefGoogle Scholar
  39. Perin MS, Fried VA, Mignery GA, Jahn R, Sudhof TC (1990) Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature 345:260–263PubMedCrossRefGoogle Scholar
  40. Rybicki AC, Heath R, Lubin B, Schwartz RS (1988) Human erythrocyte protein 4.1 is a phosphatiddylserine binding protein. J.Clin.Invest. 81:255–260PubMedCrossRefGoogle Scholar
  41. Schroit AJ, Madsen J, Tanaka Y (1985) In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J.Biol.Chem. 260:5131–5138PubMedGoogle Scholar
  42. Umeda M, Diego I, Ball ED, Marcus DM (1986) Idiotypic determinations of monoclonal antibodies that bind to 3-fucosyllactosamine. J.Immunol. 136:2562–2567PubMedGoogle Scholar
  43. Umeda M, Igarashi K, Nam K.S, Inoue K. (1989) Effective production of monoclonal antibodies against phosphatidylserine: Stereo-specific recognition of phosphatidylserine by monoclonal antibody. J.Immunol. 143:2273–2279PubMedGoogle Scholar
  44. Vehar GA, Keyt B, Eaton D, Rodriguez H, O’Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Capon DJ (1984) Structure of human factor VIII. Nature 312:337–341PubMedCrossRefGoogle Scholar
  45. Wolf M, Sahyoun N (1986) Protein kinase C and phosphatidylserine bind to Mr 110,000/115,000 polypeptides enriched in cytoskeletal and postsynaptic density. J.Biol.Chem. 261:13327–13332PubMedGoogle Scholar
  46. Wurm H (1984) Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int.J.Biochem. 16:511–515PubMedCrossRefGoogle Scholar
  47. Zenita K, Hirashima K, Shigeta K, Hiraiwa N, Takada A, Hashimoto K, Fujimoto, E, Yago, K, Kannagi R. (1990) Northern hybridization analysis of Vh gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J.Immunol. 144:4442–4451PubMedGoogle Scholar
  48. Zwaal RFA, Hemker HC (eds) (1986) Blood coagulation.Elsevier Science Publishers B.V. 141–169Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Masato Umeda
    • 1
  • Koji Igarashi
    • 1
  • Shigeru Tokita
    • 1
  • Farooq Reza
    • 1
  • Keizo Inoue
    • 1
  1. 1.Department of Health Chemistry, Faculty of Pharmaceutical SciencesThe University of TokyoBunkyo-ku, Tokyo 113Japan

Personalised recommendations